Bromelain — Research Profile

GDU (Gelatin Dissolving Units) measures bromelain's enzymatic activity, which is more important than weight (mg). A 500mg capsule could contain anywhere from 1,000 to 3,000 GDU depending on enzyme concentration. Always compare products by GDU per serving, not milligrams.

It depends on your goal. For systemic anti-inflammatory effects (swelling, pain), take on an empty stomach so the enzymes are absorbed into the bloodstream. For digestive support (protein digestion), take with meals. Most anti-inflammatory studies use between-meal dosing.

For post-surgical swelling, most clinical studies report noticeable improvement within 2-3 days, with peak benefit at 5-7 days. For chronic inflammatory conditions like OA, allow 2-4 weeks of daily use to assess effectiveness.

Stem bromelain, extracted from the pineapple stem rather than the fruit, is the form used in most clinical trials and is taken orally as capsules or tablets. For burn care, bromelain is instead applied topically by clinicians to speed wound debridement, which is a different route from the oral supplement. There is no evidence that any single branded oral form outperforms another.

The best-supported oral benefit is modest: a 2023 meta-analysis found a small but statistically significant pain reduction (mean difference -0.27 on pain score) and possible benefit for sinusitis, but no benefit for cardiovascular disease. Topical bromelain is well established for speeding burn-wound debridement, cutting time to complete debridement by roughly 6.9 days. Its anti-inflammatory effects, such as lowering IL-1beta, IL-6, and TNF-alpha, are demonstrated mainly in laboratory cell studies rather than confirmed clinical endpoints.

No standardized daily dose has been established; a 2005 osteoarthritis review explicitly concluded that trials are still needed to determine the optimum dosage. Studies have used varied preparations and durations, from a bromelain-containing enzyme combination taken over 6 weeks for knee osteoarthritis to Bromelain-POS for pediatric sinusitis, without a single agreed regimen. Because potency is measured in enzyme activity, compare products by their GDU or MCU rating rather than by milligrams alone.

Timing has not been directly compared in trials. Bromelain retains proteolytic activity in the bloodstream after oral absorption, so it can act systemically whether or not it is taken with food; dosing between meals is often suggested to favor anti-inflammatory over digestive action, though this has not been tested head-to-head. Pick a schedule you can keep to rather than a specific hour.

The most common oral side effects are mild and gastrointestinal: flatulence, nausea, and headache. Allergic reactions occur, especially in people allergic to pineapple, and one pineapple-allergic child in a sinusitis trial had a self-limiting mild allergic reaction; contact dermatitis and IgE-mediated allergy have also been reported. Serious adverse events were not seen in the systematic-review evidence.

Yes. Bromelain has antiplatelet and anticoagulant activity and may increase bleeding risk when combined with warfarin or other blood thinners. It can also raise blood and urine levels of tetracycline antibiotics, and in laboratory tests it inhibits the drug-metabolizing enzyme CYP2C9, though the clinical significance of that is not established. Use caution if you take anticoagulants or antibiotics, or if you are approaching surgery, because of the bleeding risk.

Bromelain is most reasonable for people seeking adjunctive relief of osteoarthritis pain or acute sinusitis symptoms, where oral trials show modest benefit; in burn care it is used topically by clinicians for wound debridement. It is not a proven treatment for cardiovascular disease or cancer. People with a pineapple allergy or bleeding disorders, those taking blood thinners, and anyone approaching surgery should avoid it.

Onset depends on the use. In a pediatric acute-sinusitis trial, bromelain monotherapy shortened mean symptom duration to about 6.66 days versus roughly 7.95 days with standard therapy, so relief there is measured in days. For knee osteoarthritis, a bromelain-containing enzyme combination produced measurable improvement over a 6-week course. No trial has defined a reliable universal time-to-effect for oral bromelain, so expect days to a few weeks depending on the condition.

Most bromelain trials are short, such as a 6-week comparison against diclofenac in knee osteoarthritis. A 2023 systematic review of 54 studies reported no major health risks and only mild effects like flatulence, nausea, and headache, but did not establish long-term safety. A 2005 osteoarthritis review specifically flagged the lack of prospective adverse-event monitoring for chronic use, so daily safety beyond a few weeks has not been formally demonstrated.

No upper limit or toxic oral dose has been defined for bromelain. The largest systematic review to date reported no major health risks and only mild, tolerable effects such as flatulence, nausea, and headache. Taking more than needed is most likely to cause gastrointestinal upset or, in sensitive people, an allergic reaction rather than serious toxicity.

Bromelain is commonly paired with the enzyme trypsin and the flavonoid rutosid; that combination performed comparably to diclofenac in knee osteoarthritis over 6 weeks. Because bromelain has antiplatelet and mild anticoagulant activity, stacking it with other blood-thinning supplements such as fish oil, high-dose vitamin E, garlic, or ginkgo could theoretically add to bleeding risk. No dangerous supplement-to-supplement interactions have otherwise been documented.

Bromelain potency is defined by enzyme activity rather than milligram weight, so choose a product that lists an activity level (GDU or MCU) alongside the mg amount. Bromelain is a cysteine protease isolated from the stem of the pineapple (Ananas comosus), and this stem-derived form is what most clinical work has used; the proteolytic pineapple enzyme Bromelain-POS studied in the pediatric sinusitis trials is one such preparation. Since no standardized dose is established, prioritize a clearly stated, verifiable activity level and third-party quality testing over headline milligram claims.